RMEI header logo

                                                                       

Hematologic Malignancies CME

We provide cutting edge research about newly approved and emerging treatments for leukemia, lymphoma, and myeloma to hematologists and oncologists who diagnose and treat patients with hematologic malignancies.

 

Integration of Immunotherapy into Treatment for Hematological Malignancies

This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.